Compounds > cgs 10746b
Page last updated: 2024-08-23

cgs 10746b and 3,4-dihydroxyphenylacetic acid

cgs 10746b has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altar, CA; Kim, HS; Wood, PL1

Other Studies

1 other study(ies) available for cgs 10746b and 3,4-dihydroxyphenylacetic acid

ArticleYear
Presynaptic inhibition of nigrostriatal dopamine release in the mouse: lack of cross tolerance between apomorphine, GBL and CGS 10746B.
    Life sciences, 1988, Volume: 42, Issue:16

    Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Tolerance; Efferent Pathways; Furans; Male; Mice; Substantia Nigra; Thiazepines

1988